Sort
3,198 grants matching “mrna vaccine”
Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines
$708,737Luis J. Sigal · Thomas Jefferson University · R01 · FY2025 · AI
Identifying the targets of protective immunity to severe falciparum malaria
$708,202Jonathan D. Kurtis · Brown University · R01 · FY2025 · AI
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
$707,188William Gerald Teague · University Of Virginia · R01 · FY2023 · AI
Receptor Mediated T and B Cell Activation
$706,073Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Human papillomavirus (HPV) infection and cervical and anal cancers
$705,297Nicolas Wentzensen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
COVID-19 vaccine in naive individuals and cancer patients
$704,873Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Elicitation of broad immunity using VLPs with consensus envs
$703,575Ted M Ross · University Of Pittsburgh At Pittsburgh · R01 · FY2007 · AI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS
$701,552David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Durable Vaginal Protection from HIV via mRNA expression of BNABS
$701,552Philip J Santangelo · Emory University · R01 · FY2022 · AI
Natural Immunity Against Chlamydia trachomatis
$701,131Toni Darville · Univ Of North Carolina Chapel Hill · R56 · FY2015 · AI
Development of Novel mRNA Vaccines Against Mycobacterium tuberculosis
$700,469Thomas Siegmund Postler · International Aids Vaccine Initiative · R33 · FY2025 · AI
DEVELOPMENT OF A UNIVERSAL MRNA VACCINE TARGETING APC MUTATIONS FOR COLORECTAL CANCER PREVENTION
$698,456Sloan-Kettering Institute For Cancer Research · · FY2024 · Defense Health Agency
A risk-varying and perturbed self-controlled case series design for assessing the safety of COVID-19 vaccines in a large health care system
$698,072Stanley Xu · Kaiser Foundation Research Institute · R01 · FY2025 · AI
Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma
$697,498William Gerald Teague · University Of Virginia · R01 · FY2024 · AI
Durable Vaginal Protection from HIV via mRNA expression of BNABS
$697,003Philip J Santangelo · Emory University · R01 · FY2024 · AI
Mali International Center for Excellence in Research: Parasitic Infectious Diseases and their Vectors
$696,938Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Fox COBRE Phase II Admin Core
$696,115Joseph M Fox · University Of Delaware · P20 · FY2022 · GM
Metapneumovirus Biology and Vaccine Development
$695,904Peter Leon Collins · Niaid Extramural Activities · Z01 · FY2007 · AI
mRNA-LNPs for ARDS
$694,692Hamideh Parhiz · University Of Pennsylvania · R01 · FY2024 · HL
Role of inflammation, innate resistance, and immunity in carcinogenesis
$694,605Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Improvements to Biopharmaceutical Manufacturing
$693,541Susan T Sharfstein · Hocuslocus, Inc. · R42 · FY2018 · GM
Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery
$693,256James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR
Cancer Immune-Interception for Lynch Syndrome
$692,579Eduardo Vilar Sanchez · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Software for the complete characterization of antibody repertoires: from germline and mRNA sequence assembly to deep learning predictions of their protein structures and targets
$691,914John L Schroeder · Dnastar, Inc. · R44 · FY2025 · GM
Human Papillomavirus Infection in Perinatally HIV-infected Adolescents in Asia
$690,780Annette H Sohn · Foundation For Aids Research · R01 · FY2012 · HD